Larvol

Larvol company information, Employees & Contact Information

Explore related pages

Related company profiles:

AI-powered data and market intelligence solutions - We leverage AI to transform clinical trial data and market intelligence into actionable insights to accelerate pharma innovation, competitive strategy, and patient outcomes. Our solutions include KOL monitoring, real-time high-impact news, intuitive cancer biomarker database and comprehensive conference planners. To keep you at the forefront of clinical and industry developments, LARVOL curates pharmaceutical and biotech competitive intelligence using a proven combination of broad therapeutic-area expertise and technological innovation. Our team of MDs and PhDs collates data from over 25,000 sources and distills the most relevant findings into concise reports that provide real-time insights and time-saving analysis. Our global team is comprised of professionals with expertise in all major therapeutic areas, with a special focus on oncology, inflammation, cardiovascular, and CNS. We are a valued partner to numerous Fortune 500 companies as well as small and mid-size pharma and biotech enterprises.

Company Details

Employees
139
Founded
-
Address
548 Mission St,
Phone
415-874-3310
Email
in****@****vol.com
Industry
It Services And It Consulting
NAICS
Computer Systems Design and Related Services
Other Computer Related Services
Website
larvol.com
HQ
San Francisco, California
Looking for a particular Larvol employee's phone or email?

Larvol Questions

News

Frontline Options for Metastatic EGFR-Mutated NSCLC: Taking Advantage of Opportunities, Taking Care With Tough Choices - ASCO Daily News

Frontline Options for Metastatic EGFR-Mutated NSCLC: Taking Advantage of Opportunities, Taking Care With Tough Choices ASCO Daily News

LARVOL CEO Launches One Year in the Metaverse - Business Wire

LARVOL CEO Launches One Year in the Metaverse Business Wire

Top Influencers in GU Ocology by LARVOL - Oncodaily

Top Influencers in GU Ocology by LARVOL Oncodaily

Daily Research News no. 31312 - LARVOL Debuts Cancer Sentiment Analysis Platform - printer-friendly - MrWeb

Daily Research News no. 31312 - LARVOL Debuts Cancer Sentiment Analysis Platform - printer-friendly MrWeb

EMBER-3: Imlunestrant Plus Abemaciclib Improves PFS in ER+ Breast Cancer - Docwire News

EMBER-3: Imlunestrant Plus Abemaciclib Improves PFS in ER+ Breast Cancer Docwire News

Top Larvol Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant